CGHS Approval Delays Endangering Thousands: Bureaucratic Inertia Violates Right to Life for Critically Ill Patients

The consequences of these delays are often fatal for those battling cancer, heart failure, and advanced kidney disease. T K Damodaran, General Secretary of the CGHS Beneficiaries Welfare Association of India, representing over 43 lakh beneficiaries, stated that treatment delayed is effectively life denied. The association has documented harrowing data where critical treatment windows were missed; in liver cancer cases, nearly 23% of patients saw tumors become inoperable while awaiting ablation procedure approvals. Furthermore, over 40% of lung cancer patients requiring immunotherapy experienced disease progression during the wait, while heart failure patients needing advanced devices faced delays exceeding three months, with deaths reported while files remained pending.

Medical professionals argue that this bureaucratic bottleneck undermines essential clinical judgment. A senior government hospital specialist noted that these treatments are strictly time-bound and that delayed intervention significantly worsens patient outcomes. Despite the gravity of these allegations, efforts to contact the CGHS Director for comment were unsuccessful, as he did not answer calls or respond to queries sent via WhatsApp. The crisis further intersects with significant legal precedents regarding the preservation of life. In Parmanand Katara v. Union of India, the Supreme Court held that the preservation of life is paramount, while in Paschim Banga Khet Mazdoor Samity v. State of West Bengal, the court ruled that a failure to provide timely medical treatment constitutes a violation of the right to life under Article 21 of the Constitution.

While India continues to champion technology-driven healthcare, the approval process remains archaic and centralized in Delhi, creating what health policy experts describe as profound inequity. The CGHS Beneficiaries Welfare Association has urged the government to implement urgent reforms, including the decentralization of approval powers, the establishment of strict processing timelines, and the introduction of "deemed approvals" if decisions are not rendered within a few days. They have also called for automatic clearance for elderly patients and emergency provisions for life-saving care. As Damodaran emphasized, the current disconnect remains stark: the doctor prescribes immediately, but the system responds months later, turning a fundamental right to treatment into a protracted and potentially lethal administrative ordeal.